| FEDERAL UPDATES |
CMS Proposal: Make Your Voice Heard on Medicare Part D's Six Protected Classes
On January 17, 2019, The IMF joined with over 50 patient advocacy groups in an ad campaign to ensure Medicare Part D patients continue to have access to drugs in the Six Protected Classes, which include many drugs used to treat cancer. The protected classes mandate that all available drugs in each of the six classes be accessible to patients on the plan’s formulary. A proposed rule from CMS would change this requirement and could greatly reduce patient access to treatment in each of the classes.
The IMF is prepared a comment letter specifying in detail how this proposal could impact myeloma patients, but we need you to take action too. Join IMF and let HHS know how this rule will impact people fighting myeloma!
Back to Square One for Oral Parity and Veterans Legislation
With the swearing in of the 116th Congress, we begin a new legislative session that will span over the next two years. Issues you previously took action on to help patients, such as the Cancer Drug Parity Act and the Blue Water Navy Vietnam Veterans Act will need to be reintroduced and supported by congressional members. IMF Advocacy would like to take a moment to thank those of you who acted last year to push for issues important to you and those you care about. We will continue to update and provide you with opportunities to take action as the legislative landscape progresses!
| MEDICARE |
Congressional Hearings on Health Care
The 116th Congress is kicking off with both parties talking heavily about the price of drugs. Republicans and Democrats have expressed a desire to learn more about the subject and take action.
The Senate Finance Committee chaired by Sen. Chuck Grassley (R-IA) recently held a hearing entitled ”Drug Pricing in America: A Prescription for Change, Part I.“ To view more about this hearing please click here. The House Oversight and Government Reform Committee, chaired by Rep. Elijah Cummings (D-MD) has also held a hearing on the. Information surrounding this hearing can be viewed here. The IMF will continue to monitor this issue and keep you informed.
Want to get involved?
Interested in learning more or taking actions about our federal and/or state priorities? Email the IMF Advocacy Team, firstname.lastname@example.org, to find out ways you can help and make your voice heard. Find us on the Twitter and Facebook! We will be sharing the latest news on legislation and policies we are tracking. And follow @Chemoparity for updates on our fight to get oral parity passed at the state and federal levels.
Join the conversation at The International Myeloma Foundation.